CME Group Announces Pricing Changes to Clients

What Happened
CME Group Inc. filed a Form 8-K on August 11, 2026 (Item 7.01) to disclose under Regulation FD that it communicated pricing changes to its clients through Special Executive Report No. 9799. The company posted a copy of that notice on its website. The filing was signed by Lynne Fitzpatrick, Senior Managing Director, President and Chief Financial Officer.

Key Details

• Filing date: August 11, 2026 (Form 8-K, Item 7.01: Regulation FD Disclosure).
• Notice: Special Executive Report No. 9799 communicated pricing changes to clients; copy posted on CME Group’s website.
• Administrative: Exhibit 104 (cover page in Inline XBRL) furnished with the filing.
• Signed by: Lynne Fitzpatrick (Senior Managing Director, President and Chief Financial Officer), as Principal Financial Officer and duly authorized officer.

Why It Matters
Pricing changes announced to clients can affect transaction fees, market access costs, and fee revenue streams—details investors should review to assess potential impacts on trading volumes and fees. Because this is a Regulation FD disclosure, the company has publicly posted the client notice; investors who want specifics should consult the Special Executive Report No. 9799 on CME Group’s website.